We are live!!
This was our fourth annual Precision Oncology Experimental Therapeutics (POET) meeting, but our first virtual one. COVID has definitely changed the conference world for at least a year and a half I think.
All seemed to have gone well and the feedback is good. Probably the sessions on Clinical Trial Design and Adoption of NGS in oncology were the most well received.
51
views
- 0
- 0
Comments
Sign in or get an account to comment.